Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
December 16, 2021
The GMP of AAV: Purification for Clinical Production
Cytiva
Watch this presentation to learn about the key considerations when developing a purification process for adeno-associated viruses (AAV).
>>>
Learn more
Related Content
Webcast: Repeatable, automated SPR titer assay for adeno- and adeno-associated viruses in crude samples
Successful Development of Scalable AAV Processes: Part 2 of 2
Top Challenges to Overcome When Developing AAV Processes: Part 1 of 2
Recombinant Adeno-Associated Virus Type 5 Production Process
How to Optimize and Scale Up AAV Production
See All Articles…
